Background: Increased levels of inflammation are associated with many diseases including cancer. Physical activity can lower breast cancer risk as well as levels of inflammation. The WISER-Sister trial was a randomized controlled trial that investigated the effects of a dosed moderate-to-vigorous aerobic exercise intervention on levels of inflammation in pre-menopausal women at high risk for breast cancer.Methods: Participants were randomized to control (<75 min/wk; n=41), low-dose exercise (150 min/wk; n=38) or high-dose exercise groups (300 min/wk; n=37). The 5-menstrual-cycle-long home-based treadmill exercise intervention gradually increased minutes per week and intensity up to a maximum of 80% of age-predicted heart rate max. Blood was collected at baseline and follow-up and assayed for CCL2, IL-10, IL-12 and TNFα.Results: A linear dose-response relationship was observed for pro-inflammatory biomarkers CCL2 (%Δ: −5.44% control, −0.03% low, 1.54% high), IL-12 (%Δ: −21.5% control, 38.2% low, 25.8% high ) and TNFα (%Δ: −4.69% control, 9.51% low, 15.7% high) but not for the antiinflammatory biomarker IL-10 (%Δ: 5.05% control, 6.05% low, 10.6% high). For IL-12 and TNFα, the percent change was significantly higher in the low-(IL-12: p<0.001, TNFα: p=0.01) and high-dose groups (IL-12: p<0.001, TNFα: p<0.001) compared to the control group.Conclusions: Moderate-to-vigorous aerobic exercise increased levels of pro-inflammatory biomarkers in a dose-dependent manner in a population of healthy women at high risk for developing breast cancer. These results suggest that for healthy premenopausal women, the mechanism of reduced breast cancer risk observed in physically active individuals may not be through reduced levels of inflammation.